Compile Data Set for Download or QSAR

Found 71 hits Enz. Inhib. hit(s) with all data for entry = 50000597   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kJ/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Transient receptor potential cation channel subfamily A member 1 (Rattus norvegicus)	BDBM50254439 (CHEMBL4091459) Show SMILES Fc1ccc2[nH]c(cc2c1)-c1n[nH]c2cc(OC(F)(F)F)cnc12 Show InChI InChI=1S/C15H8F4N4O/c16-8-1-2-10-7(3-8)4-11(21-10)14-13-12(22-23-14)5-9(6-20-13)24-15(17,18)19/h1-6,21H,(H,22,23)	PDB KEGG UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem Patents Similars	Article PubMed	n/a	n/a	8	n/a	n/a	n/a	n/a	n/a	n/a
Pfizer Worldwide Medicinal Chemistry, Neuroscience and Pain Research Unit, Portway Building, Granta Park, Great Abington, Cambridgeshire CB21 6GS, U.K. Curated by ChEMBL					Assay Description Inhibition of full length rat TRPA1 at a holding potential of 15 mV measured after 1 min by PatchXpress electrophysiology assay				ACS Med Chem Lett 8: 666-671 (2017) Article DOI: 10.1021/acsmedchemlett.7b00140 BindingDB Entry DOI: 10.7270/Q2C24ZWG
					More data for this Ligand-Target Pair
Transient receptor potential cation channel subfamily A member 1 (Rattus norvegicus)	BDBM50254442 (CHEMBL4095993) Show SMILES FC(F)(F)c1ccc2c(Nc3ccc(Cl)cc3)n[nH]c2c1 Show InChI InChI=1S/C14H9ClF3N3/c15-9-2-4-10(5-3-9)19-13-11-6-1-8(14(16,17)18)7-12(11)20-21-13/h1-7H,(H2,19,20,21)	PDB KEGG UniProtKB/SwissProt GoogleScholar AffyNet	Purchase PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	9	n/a	n/a	n/a	n/a	n/a	n/a
Pfizer Worldwide Medicinal Chemistry, Neuroscience and Pain Research Unit, Portway Building, Granta Park, Great Abington, Cambridgeshire CB21 6GS, U.K. Curated by ChEMBL					Assay Description Inhibition of full length rat TRPA1 at a holding potential of 15 mV measured after 1 min by PatchXpress electrophysiology assay				ACS Med Chem Lett 8: 666-671 (2017) Article DOI: 10.1021/acsmedchemlett.7b00140 BindingDB Entry DOI: 10.7270/Q2C24ZWG
					More data for this Ligand-Target Pair
Transient receptor potential cation channel subfamily A member 1 (Rattus norvegicus)	BDBM50254402 (CHEMBL4098431) Show SMILES Fc1ccc(Nc2n[nH]c3cc(ccc23)C(F)(F)F)cc1F Show InChI InChI=1S/C14H8F5N3/c15-10-4-2-8(6-11(10)16)20-13-9-3-1-7(14(17,18)19)5-12(9)21-22-13/h1-6H,(H2,20,21,22)	PDB KEGG UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	9	n/a	n/a	n/a	n/a	n/a	n/a
Pfizer Worldwide Medicinal Chemistry, Neuroscience and Pain Research Unit, Portway Building, Granta Park, Great Abington, Cambridgeshire CB21 6GS, U.K. Curated by ChEMBL					Assay Description Inhibition of full length rat TRPA1 at a holding potential of 15 mV measured after 1 min by PatchXpress electrophysiology assay				ACS Med Chem Lett 8: 666-671 (2017) Article DOI: 10.1021/acsmedchemlett.7b00140 BindingDB Entry DOI: 10.7270/Q2C24ZWG
					More data for this Ligand-Target Pair
Transient receptor potential cation channel subfamily A member 1 (Rattus norvegicus)	BDBM50254387 (CHEMBL4062193) Show SMILES Fc1ccc(Nc2n[nH]c3cc(OC(F)(F)F)cnc23)cc1F Show InChI InChI=1S/C13H7F5N4O/c14-8-2-1-6(3-9(8)15)20-12-11-10(21-22-12)4-7(5-19-11)23-13(16,17)18/h1-5H,(H2,20,21,22)	PDB KEGG UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem Patents Similars	Article PubMed	n/a	n/a	11	n/a	n/a	n/a	n/a	n/a	n/a
Pfizer Worldwide Medicinal Chemistry, Neuroscience and Pain Research Unit, Portway Building, Granta Park, Great Abington, Cambridgeshire CB21 6GS, U.K. Curated by ChEMBL					Assay Description Inhibition of rat TRPA1 at a holding potential of 15 mV measured after 1 min by whole-cell manual patch clamp electrophysiology assay				ACS Med Chem Lett 8: 666-671 (2017) Article DOI: 10.1021/acsmedchemlett.7b00140 BindingDB Entry DOI: 10.7270/Q2C24ZWG
					More data for this Ligand-Target Pair
Transient receptor potential cation channel subfamily A member 1 (Rattus norvegicus)	BDBM50254387 (CHEMBL4062193) Show SMILES Fc1ccc(Nc2n[nH]c3cc(OC(F)(F)F)cnc23)cc1F Show InChI InChI=1S/C13H7F5N4O/c14-8-2-1-6(3-9(8)15)20-12-11-10(21-22-12)4-7(5-19-11)23-13(16,17)18/h1-5H,(H2,20,21,22)	PDB KEGG UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem Patents Similars	Article PubMed	n/a	n/a	11	n/a	n/a	n/a	n/a	n/a	n/a
Pfizer Worldwide Medicinal Chemistry, Neuroscience and Pain Research Unit, Portway Building, Granta Park, Great Abington, Cambridgeshire CB21 6GS, U.K. Curated by ChEMBL					Assay Description Inhibition of full length rat TRPA1 at a holding potential of 15 mV measured after 1 min by PatchXpress electrophysiology assay				ACS Med Chem Lett 8: 666-671 (2017) Article DOI: 10.1021/acsmedchemlett.7b00140 BindingDB Entry DOI: 10.7270/Q2C24ZWG
					More data for this Ligand-Target Pair
Transient receptor potential cation channel subfamily A member 1 (Homo sapiens (Human))	BDBM50254387 (CHEMBL4062193) Show SMILES Fc1ccc(Nc2n[nH]c3cc(OC(F)(F)F)cnc23)cc1F Show InChI InChI=1S/C13H7F5N4O/c14-8-2-1-6(3-9(8)15)20-12-11-10(21-22-12)4-7(5-19-11)23-13(16,17)18/h1-5H,(H2,20,21,22)	PDB KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Patents Similars	Article PubMed	n/a	n/a	20	n/a	n/a	n/a	n/a	n/a	n/a
Pfizer Worldwide Medicinal Chemistry, Neuroscience and Pain Research Unit, Portway Building, Granta Park, Great Abington, Cambridgeshire CB21 6GS, U.K. Curated by ChEMBL					Assay Description Antagonist activity at human TRPA1 by calcium flux based FLIPR assay				ACS Med Chem Lett 8: 666-671 (2017) Article DOI: 10.1021/acsmedchemlett.7b00140 BindingDB Entry DOI: 10.7270/Q2C24ZWG
					More data for this Ligand-Target Pair
Transient receptor potential cation channel subfamily A member 1 (Rattus norvegicus)	BDBM50254406 (CHEMBL4103611) Show SMILES Fc1ccc(Nc2n[nH]c3cc(cnc23)C(F)(F)F)cc1F Show InChI InChI=1S/C13H7F5N4/c14-8-2-1-7(4-9(8)15)20-12-11-10(21-22-12)3-6(5-19-11)13(16,17)18/h1-5H,(H2,20,21,22)	PDB KEGG UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	23	n/a	n/a	n/a	n/a	n/a	n/a
Pfizer Worldwide Medicinal Chemistry, Neuroscience and Pain Research Unit, Portway Building, Granta Park, Great Abington, Cambridgeshire CB21 6GS, U.K. Curated by ChEMBL					Assay Description Inhibition of full length rat TRPA1 at a holding potential of 15 mV measured after 1 min by PatchXpress electrophysiology assay				ACS Med Chem Lett 8: 666-671 (2017) Article DOI: 10.1021/acsmedchemlett.7b00140 BindingDB Entry DOI: 10.7270/Q2C24ZWG
					More data for this Ligand-Target Pair
Transient receptor potential cation channel subfamily A member 1 (Homo sapiens (Human))	BDBM50254406 (CHEMBL4103611) Show SMILES Fc1ccc(Nc2n[nH]c3cc(cnc23)C(F)(F)F)cc1F Show InChI InChI=1S/C13H7F5N4/c14-8-2-1-7(4-9(8)15)20-12-11-10(21-22-12)3-6(5-19-11)13(16,17)18/h1-5H,(H2,20,21,22)	PDB KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	38	n/a	n/a	n/a	n/a	n/a	n/a
Pfizer Worldwide Medicinal Chemistry, Neuroscience and Pain Research Unit, Portway Building, Granta Park, Great Abington, Cambridgeshire CB21 6GS, U.K. Curated by ChEMBL					Assay Description Antagonist activity at human TRPA1 by calcium flux based FLIPR assay				ACS Med Chem Lett 8: 666-671 (2017) Article DOI: 10.1021/acsmedchemlett.7b00140 BindingDB Entry DOI: 10.7270/Q2C24ZWG
					More data for this Ligand-Target Pair
Transient receptor potential cation channel subfamily A member 1 (Homo sapiens (Human))	BDBM50254442 (CHEMBL4095993) Show SMILES FC(F)(F)c1ccc2c(Nc3ccc(Cl)cc3)n[nH]c2c1 Show InChI InChI=1S/C14H9ClF3N3/c15-9-2-4-10(5-3-9)19-13-11-6-1-8(14(16,17)18)7-12(11)20-21-13/h1-7H,(H2,19,20,21)	PDB KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	Purchase PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	42	n/a	n/a	n/a	n/a	n/a	n/a
Pfizer Worldwide Medicinal Chemistry, Neuroscience and Pain Research Unit, Portway Building, Granta Park, Great Abington, Cambridgeshire CB21 6GS, U.K. Curated by ChEMBL					Assay Description Antagonist activity at human TRPA1 by calcium flux based FLIPR assay				ACS Med Chem Lett 8: 666-671 (2017) Article DOI: 10.1021/acsmedchemlett.7b00140 BindingDB Entry DOI: 10.7270/Q2C24ZWG
					More data for this Ligand-Target Pair
Transient receptor potential cation channel subfamily A member 1 (Rattus norvegicus)	BDBM50254403 (CHEMBL4088258) Show SMILES Fc1ccc(Nc2n[nH]c3cc(Cl)ccc23)cc1F Show InChI InChI=1S/C13H8ClF2N3/c14-7-1-3-9-12(5-7)18-19-13(9)17-8-2-4-10(15)11(16)6-8/h1-6H,(H2,17,18,19)	PDB KEGG UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	49	n/a	n/a	n/a	n/a	n/a	n/a
Pfizer Worldwide Medicinal Chemistry, Neuroscience and Pain Research Unit, Portway Building, Granta Park, Great Abington, Cambridgeshire CB21 6GS, U.K. Curated by ChEMBL					Assay Description Inhibition of full length rat TRPA1 at a holding potential of 15 mV measured after 1 min by PatchXpress electrophysiology assay				ACS Med Chem Lett 8: 666-671 (2017) Article DOI: 10.1021/acsmedchemlett.7b00140 BindingDB Entry DOI: 10.7270/Q2C24ZWG
					More data for this Ligand-Target Pair
Transient receptor potential cation channel subfamily A member 1 (Homo sapiens (Human))	BDBM50254402 (CHEMBL4098431) Show SMILES Fc1ccc(Nc2n[nH]c3cc(ccc23)C(F)(F)F)cc1F Show InChI InChI=1S/C14H8F5N3/c15-10-4-2-8(6-11(10)16)20-13-9-3-1-7(14(17,18)19)5-12(9)21-22-13/h1-6H,(H2,20,21,22)	PDB KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	53	n/a	n/a	n/a	n/a	n/a	n/a
Pfizer Worldwide Medicinal Chemistry, Neuroscience and Pain Research Unit, Portway Building, Granta Park, Great Abington, Cambridgeshire CB21 6GS, U.K. Curated by ChEMBL					Assay Description Antagonist activity at human TRPA1 by calcium flux based FLIPR assay				ACS Med Chem Lett 8: 666-671 (2017) Article DOI: 10.1021/acsmedchemlett.7b00140 BindingDB Entry DOI: 10.7270/Q2C24ZWG
					More data for this Ligand-Target Pair
Transient receptor potential cation channel subfamily A member 1 (Homo sapiens (Human))	BDBM50254440 (CHEMBL4063630) Show SMILES FC(F)(F)Oc1ccc2c(n[nH]c2c1)-c1ccc(s1)C#N Show InChI InChI=1S/C13H6F3N3OS/c14-13(15,16)20-7-1-3-9-10(5-7)18-19-12(9)11-4-2-8(6-17)21-11/h1-5H,(H,18,19)	PDB KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	74	n/a	n/a	n/a	n/a	n/a	n/a
Pfizer Worldwide Medicinal Chemistry, Neuroscience and Pain Research Unit, Portway Building, Granta Park, Great Abington, Cambridgeshire CB21 6GS, U.K. Curated by ChEMBL					Assay Description Antagonist activity at human TRPA1 by calcium flux based FLIPR assay				ACS Med Chem Lett 8: 666-671 (2017) Article DOI: 10.1021/acsmedchemlett.7b00140 BindingDB Entry DOI: 10.7270/Q2C24ZWG
					More data for this Ligand-Target Pair
Transient receptor potential cation channel subfamily A member 1 (Rattus norvegicus)	BDBM50254440 (CHEMBL4063630) Show SMILES FC(F)(F)Oc1ccc2c(n[nH]c2c1)-c1ccc(s1)C#N Show InChI InChI=1S/C13H6F3N3OS/c14-13(15,16)20-7-1-3-9-10(5-7)18-19-12(9)11-4-2-8(6-17)21-11/h1-5H,(H,18,19)	PDB KEGG UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	80	n/a	n/a	n/a	n/a	n/a	n/a
Pfizer Worldwide Medicinal Chemistry, Neuroscience and Pain Research Unit, Portway Building, Granta Park, Great Abington, Cambridgeshire CB21 6GS, U.K. Curated by ChEMBL					Assay Description Inhibition of full length rat TRPA1 at a holding potential of 15 mV measured after 1 min by PatchXpress electrophysiology assay				ACS Med Chem Lett 8: 666-671 (2017) Article DOI: 10.1021/acsmedchemlett.7b00140 BindingDB Entry DOI: 10.7270/Q2C24ZWG
					More data for this Ligand-Target Pair
Transient receptor potential cation channel subfamily A member 1 (Homo sapiens (Human))	BDBM50254439 (CHEMBL4091459) Show SMILES Fc1ccc2[nH]c(cc2c1)-c1n[nH]c2cc(OC(F)(F)F)cnc12 Show InChI InChI=1S/C15H8F4N4O/c16-8-1-2-10-7(3-8)4-11(21-10)14-13-12(22-23-14)5-9(6-20-13)24-15(17,18)19/h1-6,21H,(H,22,23)	PDB KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Patents Similars	Article PubMed	n/a	n/a	91	n/a	n/a	n/a	n/a	n/a	n/a
Pfizer Worldwide Medicinal Chemistry, Neuroscience and Pain Research Unit, Portway Building, Granta Park, Great Abington, Cambridgeshire CB21 6GS, U.K. Curated by ChEMBL					Assay Description Antagonist activity at human TRPA1 by calcium flux based FLIPR assay				ACS Med Chem Lett 8: 666-671 (2017) Article DOI: 10.1021/acsmedchemlett.7b00140 BindingDB Entry DOI: 10.7270/Q2C24ZWG
					More data for this Ligand-Target Pair
Transient receptor potential cation channel subfamily A member 1 (Rattus norvegicus)	BDBM50254487 (CHEMBL4060024) Show SMILES Fc1ccc(Nc2n[nH]c3cc(OC(F)(F)F)ccc23)cc1F Show InChI InChI=1S/C14H8F5N3O/c15-10-4-1-7(5-11(10)16)20-13-9-3-2-8(23-14(17,18)19)6-12(9)21-22-13/h1-6H,(H2,20,21,22)	PDB KEGG UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	<100	n/a	n/a	n/a	n/a	n/a	n/a
Pfizer Worldwide Medicinal Chemistry, Neuroscience and Pain Research Unit, Portway Building, Granta Park, Great Abington, Cambridgeshire CB21 6GS, U.K. Curated by ChEMBL					Assay Description Inhibition of full length rat TRPA1 at a holding potential of 15 mV measured after 1 min by PatchXpress electrophysiology assay				ACS Med Chem Lett 8: 666-671 (2017) Article DOI: 10.1021/acsmedchemlett.7b00140 BindingDB Entry DOI: 10.7270/Q2C24ZWG
					More data for this Ligand-Target Pair
Transient receptor potential cation channel subfamily A member 1 (Homo sapiens (Human))	BDBM50254403 (CHEMBL4088258) Show SMILES Fc1ccc(Nc2n[nH]c3cc(Cl)ccc23)cc1F Show InChI InChI=1S/C13H8ClF2N3/c14-7-1-3-9-12(5-7)18-19-13(9)17-8-2-4-10(15)11(16)6-8/h1-6H,(H2,17,18,19)	PDB KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	111	n/a	n/a	n/a	n/a	n/a	n/a
Pfizer Worldwide Medicinal Chemistry, Neuroscience and Pain Research Unit, Portway Building, Granta Park, Great Abington, Cambridgeshire CB21 6GS, U.K. Curated by ChEMBL					Assay Description Antagonist activity at human TRPA1 by calcium flux based FLIPR assay				ACS Med Chem Lett 8: 666-671 (2017) Article DOI: 10.1021/acsmedchemlett.7b00140 BindingDB Entry DOI: 10.7270/Q2C24ZWG
					More data for this Ligand-Target Pair
Transient receptor potential cation channel subfamily A member 1 (Rattus norvegicus)	BDBM50254438 (CHEMBL4100238) Show SMILES Fc1ccc2[nH]c(cc2c1)-c1n[nH]c2cc(OC(F)(F)F)ccc12 Show InChI InChI=1S/C16H9F4N3O/c17-9-1-4-12-8(5-9)6-14(21-12)15-11-3-2-10(24-16(18,19)20)7-13(11)22-23-15/h1-7,21H,(H,22,23)	PDB KEGG UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	116	n/a	n/a	n/a	n/a	n/a	n/a
Pfizer Worldwide Medicinal Chemistry, Neuroscience and Pain Research Unit, Portway Building, Granta Park, Great Abington, Cambridgeshire CB21 6GS, U.K. Curated by ChEMBL					Assay Description Inhibition of full length rat TRPA1 at a holding potential of 15 mV measured after 1 min by PatchXpress electrophysiology assay				ACS Med Chem Lett 8: 666-671 (2017) Article DOI: 10.1021/acsmedchemlett.7b00140 BindingDB Entry DOI: 10.7270/Q2C24ZWG
					More data for this Ligand-Target Pair
Transient receptor potential cation channel subfamily A member 1 (Rattus norvegicus)	BDBM50254386 (CHEMBL4073272) Show SMILES Fc1ccc(cc1F)-c1n[nH]c2cc(OC(F)(F)F)cnc12 Show InChI InChI=1S/C13H6F5N3O/c14-8-2-1-6(3-9(8)15)11-12-10(20-21-11)4-7(5-19-12)22-13(16,17)18/h1-5H,(H,20,21)	PDB KEGG UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	128	n/a	n/a	n/a	n/a	n/a	n/a
Pfizer Worldwide Medicinal Chemistry, Neuroscience and Pain Research Unit, Portway Building, Granta Park, Great Abington, Cambridgeshire CB21 6GS, U.K. Curated by ChEMBL					Assay Description Inhibition of full length rat TRPA1 at a holding potential of 15 mV measured after 1 min by PatchXpress electrophysiology assay				ACS Med Chem Lett 8: 666-671 (2017) Article DOI: 10.1021/acsmedchemlett.7b00140 BindingDB Entry DOI: 10.7270/Q2C24ZWG
					More data for this Ligand-Target Pair
Transient receptor potential cation channel subfamily A member 1 (Homo sapiens (Human))	BDBM50254487 (CHEMBL4060024) Show SMILES Fc1ccc(Nc2n[nH]c3cc(OC(F)(F)F)ccc23)cc1F Show InChI InChI=1S/C14H8F5N3O/c15-10-4-1-7(5-11(10)16)20-13-9-3-2-8(23-14(17,18)19)6-12(9)21-22-13/h1-6H,(H2,20,21,22)	PDB KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	131	n/a	n/a	n/a	n/a	n/a	n/a
Pfizer Worldwide Medicinal Chemistry, Neuroscience and Pain Research Unit, Portway Building, Granta Park, Great Abington, Cambridgeshire CB21 6GS, U.K. Curated by ChEMBL					Assay Description Antagonist activity at human TRPA1 by calcium flux based FLIPR assay				ACS Med Chem Lett 8: 666-671 (2017) Article DOI: 10.1021/acsmedchemlett.7b00140 BindingDB Entry DOI: 10.7270/Q2C24ZWG
					More data for this Ligand-Target Pair
Transient receptor potential cation channel subfamily A member 1 (Homo sapiens (Human))	BDBM50254386 (CHEMBL4073272) Show SMILES Fc1ccc(cc1F)-c1n[nH]c2cc(OC(F)(F)F)cnc12 Show InChI InChI=1S/C13H6F5N3O/c14-8-2-1-6(3-9(8)15)11-12-10(20-21-11)4-7(5-19-12)22-13(16,17)18/h1-5H,(H,20,21)	PDB KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	134	n/a	n/a	n/a	n/a	n/a	n/a
Pfizer Worldwide Medicinal Chemistry, Neuroscience and Pain Research Unit, Portway Building, Granta Park, Great Abington, Cambridgeshire CB21 6GS, U.K. Curated by ChEMBL					Assay Description Antagonist activity at human TRPA1 by calcium flux based FLIPR assay				ACS Med Chem Lett 8: 666-671 (2017) Article DOI: 10.1021/acsmedchemlett.7b00140 BindingDB Entry DOI: 10.7270/Q2C24ZWG
					More data for this Ligand-Target Pair
Transient receptor potential cation channel subfamily A member 1 (Rattus norvegicus)	BDBM50254388 (CHEMBL4101680) Show SMILES FC(F)(F)Oc1ccc2c(n[nH]c2c1)-c1ccc(cc1)C#N Show InChI InChI=1S/C15H8F3N3O/c16-15(17,18)22-11-5-6-12-13(7-11)20-21-14(12)10-3-1-9(8-19)2-4-10/h1-7H,(H,20,21)	PDB KEGG UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	195	n/a	n/a	n/a	n/a	n/a	n/a
Pfizer Worldwide Medicinal Chemistry, Neuroscience and Pain Research Unit, Portway Building, Granta Park, Great Abington, Cambridgeshire CB21 6GS, U.K. Curated by ChEMBL					Assay Description Inhibition of rat TRPA1 at a holding potential of 15 mV measured after 1 min by whole-cell manual patch clamp electrophysiology assay				ACS Med Chem Lett 8: 666-671 (2017) Article DOI: 10.1021/acsmedchemlett.7b00140 BindingDB Entry DOI: 10.7270/Q2C24ZWG
					More data for this Ligand-Target Pair
Transient receptor potential cation channel subfamily A member 1 (Rattus norvegicus)	BDBM50254427 (CHEMBL4067095) Show SMILES Fc1ccc(cc1)-c1n[nH]c2cc(OC(F)(F)F)cnc12 Show InChI InChI=1S/C13H7F4N3O/c14-8-3-1-7(2-4-8)11-12-10(19-20-11)5-9(6-18-12)21-13(15,16)17/h1-6H,(H,19,20)	PDB KEGG UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem Patents	Article PubMed	n/a	n/a	216	n/a	n/a	n/a	n/a	n/a	n/a
Pfizer Worldwide Medicinal Chemistry, Neuroscience and Pain Research Unit, Portway Building, Granta Park, Great Abington, Cambridgeshire CB21 6GS, U.K. Curated by ChEMBL					Assay Description Inhibition of full length rat TRPA1 at a holding potential of 15 mV measured after 1 min by PatchXpress electrophysiology assay				ACS Med Chem Lett 8: 666-671 (2017) Article DOI: 10.1021/acsmedchemlett.7b00140 BindingDB Entry DOI: 10.7270/Q2C24ZWG
					More data for this Ligand-Target Pair
Transient receptor potential cation channel subfamily A member 1 (Rattus norvegicus)	BDBM50254388 (CHEMBL4101680) Show SMILES FC(F)(F)Oc1ccc2c(n[nH]c2c1)-c1ccc(cc1)C#N Show InChI InChI=1S/C15H8F3N3O/c16-15(17,18)22-11-5-6-12-13(7-11)20-21-14(12)10-3-1-9(8-19)2-4-10/h1-7H,(H,20,21)	PDB KEGG UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	246	n/a	n/a	n/a	n/a	n/a	n/a
Pfizer Worldwide Medicinal Chemistry, Neuroscience and Pain Research Unit, Portway Building, Granta Park, Great Abington, Cambridgeshire CB21 6GS, U.K. Curated by ChEMBL					Assay Description Inhibition of full length rat TRPA1 at a holding potential of 15 mV measured after 1 min by PatchXpress electrophysiology assay				ACS Med Chem Lett 8: 666-671 (2017) Article DOI: 10.1021/acsmedchemlett.7b00140 BindingDB Entry DOI: 10.7270/Q2C24ZWG
					More data for this Ligand-Target Pair
Transient receptor potential cation channel subfamily A member 1 (Rattus norvegicus)	BDBM50254441 (CHEMBL4102407) Show SMILES Fc1ccc(cc1F)-c1n[nH]c2cc(cnc12)C(F)(F)F Show InChI InChI=1S/C13H6F5N3/c14-8-2-1-6(3-9(8)15)11-12-10(20-21-11)4-7(5-19-12)13(16,17)18/h1-5H,(H,20,21)	PDB KEGG UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	255	n/a	n/a	n/a	n/a	n/a	n/a
Pfizer Worldwide Medicinal Chemistry, Neuroscience and Pain Research Unit, Portway Building, Granta Park, Great Abington, Cambridgeshire CB21 6GS, U.K. Curated by ChEMBL					Assay Description Inhibition of full length rat TRPA1 at a holding potential of 15 mV measured after 1 min by PatchXpress electrophysiology assay				ACS Med Chem Lett 8: 666-671 (2017) Article DOI: 10.1021/acsmedchemlett.7b00140 BindingDB Entry DOI: 10.7270/Q2C24ZWG
					More data for this Ligand-Target Pair
Transient receptor potential cation channel subfamily A member 1 (Homo sapiens (Human))	BDBM50254427 (CHEMBL4067095) Show SMILES Fc1ccc(cc1)-c1n[nH]c2cc(OC(F)(F)F)cnc12 Show InChI InChI=1S/C13H7F4N3O/c14-8-3-1-7(2-4-8)11-12-10(19-20-11)5-9(6-18-12)21-13(15,16)17/h1-6H,(H,19,20)	PDB KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Patents	Article PubMed	n/a	n/a	257	n/a	n/a	n/a	n/a	n/a	n/a
Pfizer Worldwide Medicinal Chemistry, Neuroscience and Pain Research Unit, Portway Building, Granta Park, Great Abington, Cambridgeshire CB21 6GS, U.K. Curated by ChEMBL					Assay Description Antagonist activity at human TRPA1 by calcium flux based FLIPR assay				ACS Med Chem Lett 8: 666-671 (2017) Article DOI: 10.1021/acsmedchemlett.7b00140 BindingDB Entry DOI: 10.7270/Q2C24ZWG
					More data for this Ligand-Target Pair
Transient receptor potential cation channel subfamily A member 1 (Rattus norvegicus)	BDBM50254385 (CHEMBL4083680) Show SMILES FC(F)(F)Oc1ccc2c(n[nH]c2c1)-c1ccc(nc1)C#N Show InChI InChI=1S/C14H7F3N4O/c15-14(16,17)22-10-3-4-11-12(5-10)20-21-13(11)8-1-2-9(6-18)19-7-8/h1-5,7H,(H,20,21)	PDB KEGG UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem Patents Similars	Article PubMed	n/a	n/a	271	n/a	n/a	n/a	n/a	n/a	n/a
Pfizer Worldwide Medicinal Chemistry, Neuroscience and Pain Research Unit, Portway Building, Granta Park, Great Abington, Cambridgeshire CB21 6GS, U.K. Curated by ChEMBL					Assay Description Inhibition of full length rat TRPA1 at a holding potential of 15 mV measured after 1 min by PatchXpress electrophysiology assay				ACS Med Chem Lett 8: 666-671 (2017) Article DOI: 10.1021/acsmedchemlett.7b00140 BindingDB Entry DOI: 10.7270/Q2C24ZWG
					More data for this Ligand-Target Pair
Transient receptor potential cation channel subfamily A member 1 (Rattus norvegicus)	BDBM50254426 (CHEMBL4061751) Show SMILES Fc1ccc(cc1F)-c1n[nH]c2cc(ccc12)C(F)(F)F Show InChI InChI=1S/C14H7F5N2/c15-10-4-1-7(5-11(10)16)13-9-3-2-8(14(17,18)19)6-12(9)20-21-13/h1-6H,(H,20,21)	PDB KEGG UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	329	n/a	n/a	n/a	n/a	n/a	n/a
Pfizer Worldwide Medicinal Chemistry, Neuroscience and Pain Research Unit, Portway Building, Granta Park, Great Abington, Cambridgeshire CB21 6GS, U.K. Curated by ChEMBL					Assay Description Inhibition of full length rat TRPA1 at a holding potential of 15 mV measured after 1 min by PatchXpress electrophysiology assay				ACS Med Chem Lett 8: 666-671 (2017) Article DOI: 10.1021/acsmedchemlett.7b00140 BindingDB Entry DOI: 10.7270/Q2C24ZWG
					More data for this Ligand-Target Pair
Transient receptor potential cation channel subfamily A member 1 (Homo sapiens (Human))	BDBM50254387 (CHEMBL4062193) Show SMILES Fc1ccc(Nc2n[nH]c3cc(OC(F)(F)F)cnc23)cc1F Show InChI InChI=1S/C13H7F5N4O/c14-8-2-1-6(3-9(8)15)20-12-11-10(21-22-12)4-7(5-19-11)23-13(16,17)18/h1-5H,(H2,20,21,22)	PDB KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Patents Similars	Article PubMed	n/a	n/a	330	n/a	n/a	n/a	n/a	n/a	n/a
Pfizer Worldwide Medicinal Chemistry, Neuroscience and Pain Research Unit, Portway Building, Granta Park, Great Abington, Cambridgeshire CB21 6GS, U.K. Curated by ChEMBL					Assay Description Antagonist activity at human TRPA1 by calcium flux based FLIPR assay				ACS Med Chem Lett 8: 666-671 (2017) Article DOI: 10.1021/acsmedchemlett.7b00140 BindingDB Entry DOI: 10.7270/Q2C24ZWG
					More data for this Ligand-Target Pair
Transient receptor potential cation channel subfamily A member 1 (Homo sapiens (Human))	BDBM50254441 (CHEMBL4102407) Show SMILES Fc1ccc(cc1F)-c1n[nH]c2cc(cnc12)C(F)(F)F Show InChI InChI=1S/C13H6F5N3/c14-8-2-1-6(3-9(8)15)11-12-10(20-21-11)4-7(5-19-12)13(16,17)18/h1-5H,(H,20,21)	PDB KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	450	n/a	n/a	n/a	n/a	n/a	n/a
Pfizer Worldwide Medicinal Chemistry, Neuroscience and Pain Research Unit, Portway Building, Granta Park, Great Abington, Cambridgeshire CB21 6GS, U.K. Curated by ChEMBL					Assay Description Antagonist activity at human TRPA1 by calcium flux based FLIPR assay				ACS Med Chem Lett 8: 666-671 (2017) Article DOI: 10.1021/acsmedchemlett.7b00140 BindingDB Entry DOI: 10.7270/Q2C24ZWG
					More data for this Ligand-Target Pair
Transient receptor potential cation channel subfamily A member 1 (Rattus norvegicus)	BDBM50254489 (CHEMBL4075615) Show SMILES COCCNC(=O)c1ccc2c(n[nH]c2c1)-c1ccc(cc1)C#N Show InChI InChI=1S/C18H16N4O2/c1-24-9-8-20-18(23)14-6-7-15-16(10-14)21-22-17(15)13-4-2-12(11-19)3-5-13/h2-7,10H,8-9H2,1H3,(H,20,23)(H,21,22)	PDB KEGG UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem Patents Similars	Article PubMed	n/a	n/a	453	n/a	n/a	n/a	n/a	n/a	n/a
Pfizer Worldwide Medicinal Chemistry, Neuroscience and Pain Research Unit, Portway Building, Granta Park, Great Abington, Cambridgeshire CB21 6GS, U.K. Curated by ChEMBL					Assay Description Inhibition of full length rat TRPA1 at a holding potential of 15 mV measured after 1 min by PatchXpress electrophysiology assay				ACS Med Chem Lett 8: 666-671 (2017) Article DOI: 10.1021/acsmedchemlett.7b00140 BindingDB Entry DOI: 10.7270/Q2C24ZWG
					More data for this Ligand-Target Pair
Transient receptor potential cation channel subfamily A member 1 (Homo sapiens (Human))	BDBM50254401 (CHEMBL4093377) Show SMILES FC(F)(F)c1ccc2c(Nc3ccc(Cl)nc3)n[nH]c2c1 Show InChI InChI=1S/C13H8ClF3N4/c14-11-4-2-8(6-18-11)19-12-9-3-1-7(13(15,16)17)5-10(9)20-21-12/h1-6H,(H2,19,20,21)	PDB KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	550	n/a	n/a	n/a	n/a	n/a	n/a
Pfizer Worldwide Medicinal Chemistry, Neuroscience and Pain Research Unit, Portway Building, Granta Park, Great Abington, Cambridgeshire CB21 6GS, U.K. Curated by ChEMBL					Assay Description Inhibition of full length human TRPA1 at a holding potential of 15 mV measured after 1 min by PatchXpress electrophysiology assay				ACS Med Chem Lett 8: 666-671 (2017) Article DOI: 10.1021/acsmedchemlett.7b00140 BindingDB Entry DOI: 10.7270/Q2C24ZWG
					More data for this Ligand-Target Pair
Transient receptor potential cation channel subfamily A member 1 (Homo sapiens (Human))	BDBM50254488 (CHEMBL4072845) Show SMILES Fc1ccc(Nc2n[nH]c3cc(ncc23)C(F)(F)F)cc1F Show InChI InChI=1S/C13H7F5N4/c14-8-2-1-6(3-9(8)15)20-12-7-5-19-11(13(16,17)18)4-10(7)21-22-12/h1-5H,(H2,20,21,22)	PDB KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Patents Similars	Article PubMed	n/a	n/a	645	n/a	n/a	n/a	n/a	n/a	n/a
Pfizer Worldwide Medicinal Chemistry, Neuroscience and Pain Research Unit, Portway Building, Granta Park, Great Abington, Cambridgeshire CB21 6GS, U.K. Curated by ChEMBL					Assay Description Antagonist activity at human TRPA1 by calcium flux based FLIPR assay				ACS Med Chem Lett 8: 666-671 (2017) Article DOI: 10.1021/acsmedchemlett.7b00140 BindingDB Entry DOI: 10.7270/Q2C24ZWG
					More data for this Ligand-Target Pair
Transient receptor potential cation channel subfamily A member 1 (Homo sapiens (Human))	BDBM50254388 (CHEMBL4101680) Show SMILES FC(F)(F)Oc1ccc2c(n[nH]c2c1)-c1ccc(cc1)C#N Show InChI InChI=1S/C15H8F3N3O/c16-15(17,18)22-11-5-6-12-13(7-11)20-21-14(12)10-3-1-9(8-19)2-4-10/h1-7H,(H,20,21)	PDB KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	686	n/a	n/a	n/a	n/a	n/a	n/a
Pfizer Worldwide Medicinal Chemistry, Neuroscience and Pain Research Unit, Portway Building, Granta Park, Great Abington, Cambridgeshire CB21 6GS, U.K. Curated by ChEMBL					Assay Description Antagonist activity at human TRPA1 by calcium flux based FLIPR assay				ACS Med Chem Lett 8: 666-671 (2017) Article DOI: 10.1021/acsmedchemlett.7b00140 BindingDB Entry DOI: 10.7270/Q2C24ZWG
					More data for this Ligand-Target Pair
Transient receptor potential cation channel subfamily A member 1 (Homo sapiens (Human))	BDBM50254438 (CHEMBL4100238) Show SMILES Fc1ccc2[nH]c(cc2c1)-c1n[nH]c2cc(OC(F)(F)F)ccc12 Show InChI InChI=1S/C16H9F4N3O/c17-9-1-4-12-8(5-9)6-14(21-12)15-11-3-2-10(24-16(18,19)20)7-13(11)22-23-15/h1-7,21H,(H,22,23)	PDB KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	748	n/a	n/a	n/a	n/a	n/a	n/a
Pfizer Worldwide Medicinal Chemistry, Neuroscience and Pain Research Unit, Portway Building, Granta Park, Great Abington, Cambridgeshire CB21 6GS, U.K. Curated by ChEMBL					Assay Description Antagonist activity at human TRPA1 by calcium flux based FLIPR assay				ACS Med Chem Lett 8: 666-671 (2017) Article DOI: 10.1021/acsmedchemlett.7b00140 BindingDB Entry DOI: 10.7270/Q2C24ZWG
					More data for this Ligand-Target Pair
Transient receptor potential cation channel subfamily A member 1 (Rattus norvegicus)	BDBM50254425 (CHEMBL4067996) Show SMILES Fc1ccc(Nc2n[nH]c3cc(OC(F)(F)F)cnc23)nc1 Show InChI InChI=1S/C12H7F4N5O/c13-6-1-2-9(17-4-6)19-11-10-8(20-21-11)3-7(5-18-10)22-12(14,15)16/h1-5H,(H2,17,19,20,21)	PDB KEGG UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem Patents Similars	Article PubMed	n/a	n/a	813	n/a	n/a	n/a	n/a	n/a	n/a
Pfizer Worldwide Medicinal Chemistry, Neuroscience and Pain Research Unit, Portway Building, Granta Park, Great Abington, Cambridgeshire CB21 6GS, U.K. Curated by ChEMBL					Assay Description Inhibition of full length rat TRPA1 at a holding potential of 15 mV measured after 1 min by PatchXpress electrophysiology assay				ACS Med Chem Lett 8: 666-671 (2017) Article DOI: 10.1021/acsmedchemlett.7b00140 BindingDB Entry DOI: 10.7270/Q2C24ZWG
					More data for this Ligand-Target Pair
Transient receptor potential cation channel subfamily A member 1 (Homo sapiens (Human))	BDBM50254385 (CHEMBL4083680) Show SMILES FC(F)(F)Oc1ccc2c(n[nH]c2c1)-c1ccc(nc1)C#N Show InChI InChI=1S/C14H7F3N4O/c15-14(16,17)22-10-3-4-11-12(5-10)20-21-13(11)8-1-2-9(6-18)19-7-8/h1-5,7H,(H,20,21)	PDB KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Patents Similars	Article PubMed	n/a	n/a	1.18E+3	n/a	n/a	n/a	n/a	n/a	n/a
Pfizer Worldwide Medicinal Chemistry, Neuroscience and Pain Research Unit, Portway Building, Granta Park, Great Abington, Cambridgeshire CB21 6GS, U.K. Curated by ChEMBL					Assay Description Antagonist activity at human TRPA1 by calcium flux based FLIPR assay				ACS Med Chem Lett 8: 666-671 (2017) Article DOI: 10.1021/acsmedchemlett.7b00140 BindingDB Entry DOI: 10.7270/Q2C24ZWG
					More data for this Ligand-Target Pair
Transient receptor potential cation channel subfamily A member 1 (Homo sapiens (Human))	BDBM50254404 (CHEMBL4061022) Show SMILES Fc1ccc(Nc2n[nH]c3c(OC(F)(F)F)cccc23)cc1F Show InChI InChI=1S/C14H8F5N3O/c15-9-5-4-7(6-10(9)16)20-13-8-2-1-3-11(12(8)21-22-13)23-14(17,18)19/h1-6H,(H2,20,21,22)	PDB KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	1.20E+3	n/a	n/a	n/a	n/a	n/a	n/a
Pfizer Worldwide Medicinal Chemistry, Neuroscience and Pain Research Unit, Portway Building, Granta Park, Great Abington, Cambridgeshire CB21 6GS, U.K. Curated by ChEMBL					Assay Description Antagonist activity at human TRPA1 by calcium flux based FLIPR assay				ACS Med Chem Lett 8: 666-671 (2017) Article DOI: 10.1021/acsmedchemlett.7b00140 BindingDB Entry DOI: 10.7270/Q2C24ZWG
					More data for this Ligand-Target Pair
Transient receptor potential cation channel subfamily A member 1 (Rattus norvegicus)	BDBM50254428 (CHEMBL4079870) Show SMILES Fc1ccc(cc1)-c1n[nH]c2cc(NC3CCN(CC4CC4)CC3)cnc12 Show InChI InChI=1S/C21H24FN5/c22-16-5-3-15(4-6-16)20-21-19(25-26-20)11-18(12-23-21)24-17-7-9-27(10-8-17)13-14-1-2-14/h3-6,11-12,14,17,24H,1-2,7-10,13H2,(H,25,26)	PDB KEGG UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem Patents Similars	Article PubMed	n/a	n/a	1.85E+3	n/a	n/a	n/a	n/a	n/a	n/a
Pfizer Worldwide Medicinal Chemistry, Neuroscience and Pain Research Unit, Portway Building, Granta Park, Great Abington, Cambridgeshire CB21 6GS, U.K. Curated by ChEMBL					Assay Description Inhibition of full length rat TRPA1 at a holding potential of 15 mV measured after 1 min by PatchXpress electrophysiology assay				ACS Med Chem Lett 8: 666-671 (2017) Article DOI: 10.1021/acsmedchemlett.7b00140 BindingDB Entry DOI: 10.7270/Q2C24ZWG
					More data for this Ligand-Target Pair
Transient receptor potential cation channel subfamily A member 1 (Homo sapiens (Human))	BDBM50254426 (CHEMBL4061751) Show SMILES Fc1ccc(cc1F)-c1n[nH]c2cc(ccc12)C(F)(F)F Show InChI InChI=1S/C14H7F5N2/c15-10-4-1-7(5-11(10)16)13-9-3-2-8(14(17,18)19)6-12(9)20-21-13/h1-6H,(H,20,21)	PDB KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	2.10E+3	n/a	n/a	n/a	n/a	n/a	n/a
Pfizer Worldwide Medicinal Chemistry, Neuroscience and Pain Research Unit, Portway Building, Granta Park, Great Abington, Cambridgeshire CB21 6GS, U.K. Curated by ChEMBL					Assay Description Antagonist activity at human TRPA1 by calcium flux based FLIPR assay				ACS Med Chem Lett 8: 666-671 (2017) Article DOI: 10.1021/acsmedchemlett.7b00140 BindingDB Entry DOI: 10.7270/Q2C24ZWG
					More data for this Ligand-Target Pair
Transient receptor potential cation channel subfamily A member 1 (Homo sapiens (Human))	BDBM50254401 (CHEMBL4093377) Show SMILES FC(F)(F)c1ccc2c(Nc3ccc(Cl)nc3)n[nH]c2c1 Show InChI InChI=1S/C13H8ClF3N4/c14-11-4-2-8(6-18-11)19-12-9-3-1-7(13(15,16)17)5-10(9)20-21-12/h1-6H,(H2,19,20,21)	PDB KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	2.50E+3	n/a	n/a	n/a	n/a	n/a	n/a
Pfizer Worldwide Medicinal Chemistry, Neuroscience and Pain Research Unit, Portway Building, Granta Park, Great Abington, Cambridgeshire CB21 6GS, U.K. Curated by ChEMBL					Assay Description Antagonist activity at human TRPA1 by calcium flux based FLIPR assay				ACS Med Chem Lett 8: 666-671 (2017) Article DOI: 10.1021/acsmedchemlett.7b00140 BindingDB Entry DOI: 10.7270/Q2C24ZWG
					More data for this Ligand-Target Pair
Transient receptor potential cation channel subfamily A member 1 (Homo sapiens (Human))	BDBM50254425 (CHEMBL4067996) Show SMILES Fc1ccc(Nc2n[nH]c3cc(OC(F)(F)F)cnc23)nc1 Show InChI InChI=1S/C12H7F4N5O/c13-6-1-2-9(17-4-6)19-11-10-8(20-21-11)3-7(5-18-10)22-12(14,15)16/h1-5H,(H2,17,19,20,21)	PDB KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Patents Similars	Article PubMed	n/a	n/a	2.54E+3	n/a	n/a	n/a	n/a	n/a	n/a
Pfizer Worldwide Medicinal Chemistry, Neuroscience and Pain Research Unit, Portway Building, Granta Park, Great Abington, Cambridgeshire CB21 6GS, U.K. Curated by ChEMBL					Assay Description Antagonist activity at human TRPA1 by calcium flux based FLIPR assay				ACS Med Chem Lett 8: 666-671 (2017) Article DOI: 10.1021/acsmedchemlett.7b00140 BindingDB Entry DOI: 10.7270/Q2C24ZWG
					More data for this Ligand-Target Pair
Potassium voltage-gated channel subfamily KQT member 1 (Homo sapiens (Human))	BDBM50254401 (CHEMBL4093377) Show SMILES FC(F)(F)c1ccc2c(Nc3ccc(Cl)nc3)n[nH]c2c1 Show InChI InChI=1S/C13H8ClF3N4/c14-11-4-2-8(6-18-11)19-12-9-3-1-7(13(15,16)17)5-10(9)20-21-12/h1-6H,(H2,19,20,21)	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	2.60E+3	n/a	n/a	n/a	n/a	n/a	n/a
Pfizer Worldwide Medicinal Chemistry, Neuroscience and Pain Research Unit, Portway Building, Granta Park, Great Abington, Cambridgeshire CB21 6GS, U.K. Curated by ChEMBL					Assay Description Inhibition of KCNQ1 (unknown origin)				ACS Med Chem Lett 8: 666-671 (2017) Article DOI: 10.1021/acsmedchemlett.7b00140 BindingDB Entry DOI: 10.7270/Q2C24ZWG
					More data for this Ligand-Target Pair
Potassium voltage-gated channel subfamily KQT member 1 (Homo sapiens (Human))	BDBM50254387 (CHEMBL4062193) Show SMILES Fc1ccc(Nc2n[nH]c3cc(OC(F)(F)F)cnc23)cc1F Show InChI InChI=1S/C13H7F5N4O/c14-8-2-1-6(3-9(8)15)20-12-11-10(21-22-12)4-7(5-19-11)23-13(16,17)18/h1-5H,(H2,20,21,22)	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Patents Similars	Article PubMed	n/a	n/a	2.64E+3	n/a	n/a	n/a	n/a	n/a	n/a
Pfizer Worldwide Medicinal Chemistry, Neuroscience and Pain Research Unit, Portway Building, Granta Park, Great Abington, Cambridgeshire CB21 6GS, U.K. Curated by ChEMBL					Assay Description Inhibition of KCNQ1 (unknown origin)				ACS Med Chem Lett 8: 666-671 (2017) Article DOI: 10.1021/acsmedchemlett.7b00140 BindingDB Entry DOI: 10.7270/Q2C24ZWG
					More data for this Ligand-Target Pair
Transient receptor potential cation channel subfamily A member 1 (Homo sapiens (Human))	BDBM50254489 (CHEMBL4075615) Show SMILES COCCNC(=O)c1ccc2c(n[nH]c2c1)-c1ccc(cc1)C#N Show InChI InChI=1S/C18H16N4O2/c1-24-9-8-20-18(23)14-6-7-15-16(10-14)21-22-17(15)13-4-2-12(11-19)3-5-13/h2-7,10H,8-9H2,1H3,(H,20,23)(H,21,22)	PDB KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Patents Similars	Article PubMed	n/a	n/a	2.67E+3	n/a	n/a	n/a	n/a	n/a	n/a
Pfizer Worldwide Medicinal Chemistry, Neuroscience and Pain Research Unit, Portway Building, Granta Park, Great Abington, Cambridgeshire CB21 6GS, U.K. Curated by ChEMBL					Assay Description Antagonist activity at human TRPA1 by calcium flux based FLIPR assay				ACS Med Chem Lett 8: 666-671 (2017) Article DOI: 10.1021/acsmedchemlett.7b00140 BindingDB Entry DOI: 10.7270/Q2C24ZWG
					More data for this Ligand-Target Pair
Potassium voltage-gated channel subfamily KQT member 1 (Homo sapiens (Human))	BDBM50254388 (CHEMBL4101680) Show SMILES FC(F)(F)Oc1ccc2c(n[nH]c2c1)-c1ccc(cc1)C#N Show InChI InChI=1S/C15H8F3N3O/c16-15(17,18)22-11-5-6-12-13(7-11)20-21-14(12)10-3-1-9(8-19)2-4-10/h1-7H,(H,20,21)	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	>3.00E+3	n/a	n/a	n/a	n/a	n/a	n/a
Pfizer Worldwide Medicinal Chemistry, Neuroscience and Pain Research Unit, Portway Building, Granta Park, Great Abington, Cambridgeshire CB21 6GS, U.K. Curated by ChEMBL					Assay Description Inhibition of KCNQ1 (unknown origin)				ACS Med Chem Lett 8: 666-671 (2017) Article DOI: 10.1021/acsmedchemlett.7b00140 BindingDB Entry DOI: 10.7270/Q2C24ZWG
					More data for this Ligand-Target Pair
Transient receptor potential cation channel subfamily A member 1 (Homo sapiens (Human))	BDBM50254405 (CHEMBL4082907) Show SMILES Fc1ccc(Nc2n[nH]c3cc(ccc23)-c2ccc(F)c(F)c2)cc1F Show InChI InChI=1S/C19H11F4N3/c20-14-5-2-10(7-16(14)22)11-1-4-13-18(8-11)25-26-19(13)24-12-3-6-15(21)17(23)9-12/h1-9H,(H2,24,25,26)	PDB KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	3.70E+3	n/a	n/a	n/a	n/a	n/a	n/a
Pfizer Worldwide Medicinal Chemistry, Neuroscience and Pain Research Unit, Portway Building, Granta Park, Great Abington, Cambridgeshire CB21 6GS, U.K. Curated by ChEMBL					Assay Description Antagonist activity at human TRPA1 by calcium flux based FLIPR assay				ACS Med Chem Lett 8: 666-671 (2017) Article DOI: 10.1021/acsmedchemlett.7b00140 BindingDB Entry DOI: 10.7270/Q2C24ZWG
					More data for this Ligand-Target Pair
Transient receptor potential cation channel subfamily A member 1 (Homo sapiens (Human))	BDBM50254428 (CHEMBL4079870) Show SMILES Fc1ccc(cc1)-c1n[nH]c2cc(NC3CCN(CC4CC4)CC3)cnc12 Show InChI InChI=1S/C21H24FN5/c22-16-5-3-15(4-6-16)20-21-19(25-26-20)11-18(12-23-21)24-17-7-9-27(10-8-17)13-14-1-2-14/h3-6,11-12,14,17,24H,1-2,7-10,13H2,(H,25,26)	PDB KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Patents Similars	Article PubMed	n/a	n/a	4.63E+3	n/a	n/a	n/a	n/a	n/a	n/a
Pfizer Worldwide Medicinal Chemistry, Neuroscience and Pain Research Unit, Portway Building, Granta Park, Great Abington, Cambridgeshire CB21 6GS, U.K. Curated by ChEMBL					Assay Description Antagonist activity at human TRPA1 by calcium flux based FLIPR assay				ACS Med Chem Lett 8: 666-671 (2017) Article DOI: 10.1021/acsmedchemlett.7b00140 BindingDB Entry DOI: 10.7270/Q2C24ZWG
					More data for this Ligand-Target Pair
Sodium channel protein type 5 subunit alpha (Homo sapiens (Human))	BDBM50254401 (CHEMBL4093377) Show SMILES FC(F)(F)c1ccc2c(Nc3ccc(Cl)nc3)n[nH]c2c1 Show InChI InChI=1S/C13H8ClF3N4/c14-11-4-2-8(6-18-11)19-12-9-3-1-7(13(15,16)17)5-10(9)20-21-12/h1-6H,(H2,19,20,21)	PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	8.52E+3	n/a	n/a	n/a	n/a	n/a	n/a
Pfizer Worldwide Medicinal Chemistry, Neuroscience and Pain Research Unit, Portway Building, Granta Park, Great Abington, Cambridgeshire CB21 6GS, U.K. Curated by ChEMBL					Assay Description Inhibition of Nav1.5 (unknown origin)				ACS Med Chem Lett 8: 666-671 (2017) Article DOI: 10.1021/acsmedchemlett.7b00140 BindingDB Entry DOI: 10.7270/Q2C24ZWG
					More data for this Ligand-Target Pair
Sodium channel protein type 9 subunit alpha (Homo sapiens (Human))	BDBM50254387 (CHEMBL4062193) Show SMILES Fc1ccc(Nc2n[nH]c3cc(OC(F)(F)F)cnc23)cc1F Show InChI InChI=1S/C13H7F5N4O/c14-8-2-1-6(3-9(8)15)20-12-11-10(21-22-12)4-7(5-19-11)23-13(16,17)18/h1-5H,(H2,20,21,22)	PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Patents Similars	Article PubMed	n/a	n/a	8.70E+3	n/a	n/a	n/a	n/a	n/a	n/a
Pfizer Worldwide Medicinal Chemistry, Neuroscience and Pain Research Unit, Portway Building, Granta Park, Great Abington, Cambridgeshire CB21 6GS, U.K. Curated by ChEMBL					Assay Description Inhibition of Nav1.7 (unknown origin)				ACS Med Chem Lett 8: 666-671 (2017) Article DOI: 10.1021/acsmedchemlett.7b00140 BindingDB Entry DOI: 10.7270/Q2C24ZWG
					More data for this Ligand-Target Pair
Transient receptor potential cation channel subfamily A member 1 (Homo sapiens (Human))	BDBM50254453 (CHEMBL4079487) Show SMILES CN(c1nn(C)c2cc(ccc12)C(F)(F)F)c1ccc(Cl)nc1 Show InChI InChI=1S/C15H12ClF3N4/c1-22(10-4-6-13(16)20-8-10)14-11-5-3-9(15(17,18)19)7-12(11)23(2)21-14/h3-8H,1-2H3	PDB KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	>1.00E+4	n/a	n/a	n/a	n/a	n/a	n/a
Pfizer Worldwide Medicinal Chemistry, Neuroscience and Pain Research Unit, Portway Building, Granta Park, Great Abington, Cambridgeshire CB21 6GS, U.K. Curated by ChEMBL					Assay Description Antagonist activity at human TRPA1 by calcium flux based FLIPR assay				ACS Med Chem Lett 8: 666-671 (2017) Article DOI: 10.1021/acsmedchemlett.7b00140 BindingDB Entry DOI: 10.7270/Q2C24ZWG
					More data for this Ligand-Target Pair

Displayed 1 to 50 (of 71 total )  |  Next  |  Last  >>

Jump to: